GSK3640254 Tablet

DRUG2 trials

Sponsors

ViiV Healthcare

Conditions

HIV Infections

Phase 1

A Relative Bioavailability and Food-Effect Study of GSK3640254 Tablet and Capsule Formulations in Healthy Participants

TerminatedNCT04128293

ViiV HealthcareHIV Infections

Start: 2019-10-08End: 2019-11-15Updated: 2020-08-25

A Relative Bioavailability and Food-Effect Study of GSK3640254 Tablet and Capsule Formulations in Healthy Participants

CompletedNCT04263142

ViiV HealthcareHIV Infections

Start: 2020-01-27End: 2020-03-24Updated: 2021-03-03

Related Papers

Relative Bioavailability and Food Effect of GSK3640254 Tablet and Capsule Formulations in Healthy Participants

Clinical Pharmacology in Drug Development2022-01-075 citations